These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 2467380
1. Control of angiogenesis with synthetic heparin substitutes. Folkman J, Weisz PB, Joullié MM, Li WW, Ewing WR. Science; 1989 Mar 17; 243(4897):1490-3. PubMed ID: 2467380 [Abstract] [Full Text] [Related]
2. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Crum R, Szabo S, Folkman J. Science; 1985 Dec 20; 230(4732):1375-8. PubMed ID: 2416056 [Abstract] [Full Text] [Related]
4. Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase. Chen NT, Corey EJ, Folkman J. Lab Invest; 1988 Oct 20; 59(4):453-9. PubMed ID: 2459497 [Abstract] [Full Text] [Related]
6. Angiostatic steroids. Method of discovery and mechanism of action. Folkman J, Ingber DE. Ann Surg; 1987 Sep 20; 206(3):374-83. PubMed ID: 2443088 [Abstract] [Full Text] [Related]
7. The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat. Proia AD, Hirakata A, McInnes JS, Scroggs MW, Parikh I. Exp Eye Res; 1993 Dec 20; 57(6):693-8. PubMed ID: 7512045 [Abstract] [Full Text] [Related]
9. [Protective effects of cyclodextrin on the local irritation induced by aqueous preparations of flurbiprofen]. Masuda K, Ito A, Ikari T, Terashima A, Matsuyama T. Yakugaku Zasshi; 1984 Oct 20; 104(10):1075-82. PubMed ID: 6530654 [No Abstract] [Full Text] [Related]
10. Analysis of interfacial transfer and absorption behavior of drugs following dissolution from beta-cyclodextrin complexes. Uekama K, Uemura Y, Irie T, Otagiri M. Chem Pharm Bull (Tokyo); 1983 Oct 20; 31(10):3637-43. PubMed ID: 6671224 [No Abstract] [Full Text] [Related]
11. [Enhanced bioavailability of acetohexamide by beta-cyclodextrin complexation (author's transl)]. Uekama K, Matsuo N, Hirayama F, Ichibagase H, Arimori K, Tsubaki K, Satake K. Yakugaku Zasshi; 1980 Sep 20; 100(9):903-9. PubMed ID: 7218151 [No Abstract] [Full Text] [Related]
12. Inhibition of angiogenesis by suramin. Gagliardi A, Hadd H, Collins DC. Cancer Res; 1992 Sep 15; 52(18):5073-5. PubMed ID: 1381276 [Abstract] [Full Text] [Related]
13. [Effect of dimethyl beta-cyclodextrin on oral or rectal absorption of 1-hexylcarbamoyl-5-fluorouracil (HCFU)]. Kikuchi M, Uekama K. Yakugaku Zasshi; 1988 Feb 15; 108(2):156-63. PubMed ID: 3404404 [No Abstract] [Full Text] [Related]
15. Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations. Seo H, Tsuruoka M, Hashimoto T, Fujinaga T, Otagiri M, Uekama K. Chem Pharm Bull (Tokyo); 1983 Jan 15; 31(1):286-91. PubMed ID: 6850944 [No Abstract] [Full Text] [Related]
16. Inhibition of angiogenesis by aurintricarboxylic acid. Gagliardi AR, Collins DC. Anticancer Res; 1994 Jan 15; 14(2A):475-9. PubMed ID: 7517120 [Abstract] [Full Text] [Related]
19. Reduction in the local tissue toxicity of chlorpromazine by beta-cyclodextrin complexation. Irie T, Kuwahara S, Otagiri M, Uekama K, Iwamasa T. J Pharmacobiodyn; 1983 Oct 15; 6(10):790-2. PubMed ID: 6663444 [Abstract] [Full Text] [Related]